A carregar...

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development

Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation vaccine against smallpox and serves as a potent vector system for development of new candidate vaccines against infectious diseases and cancer. Historically, MVA was developed by serial tissue culture passage in prima...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Virus Res
Main Authors: Volz, A., Sutter, G.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Inc. 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7112317/
https://ncbi.nlm.nih.gov/pubmed/28057259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.aivir.2016.07.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!